AHL
WVE icon

Abel Hall LLC’s Wave Life Sciences WVE Stock Holding History

Abel Hall LLC’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3K Buy
+16,569
New +$110K 0.02% 841

Other funds holding WVE

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Abel Hall LLC's WVE Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Wave Life Sciences (WVE) in Q2 2026: 16,569 shares worth $96.3K. The stake represents 0.02% of the portfolio and ranks #841 among its holdings.

30 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Abel Hall LLC held 16,569 shares of Wave Life Sciences worth $96.3K as of Q2 2026.
  • Wave Life Sciences was a new Abel Hall LLC position in Q2 2026.
  • Wave Life Sciences made up 0.02% of Abel Hall LLC's portfolio in Q2 2026, its #841 holding.
  • 30 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.